These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1752061)

  • 1. Treatment with biosynthetic growth hormone of short thalassaemic patients with impaired growth hormone secretion.
    Scacchi M; Danesi L; De Martin M; Dubini A; Forni L; Masala A; Gallisai D; Burrai C; Terzoli S; Boffa C
    Clin Endocrinol (Oxf); 1991 Oct; 35(4):335-9. PubMed ID: 1752061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone treatment of short Chinese children with beta-thalassaemia major without GH deficiency.
    Low LC; Kwan EY; Lim YJ; Lee AC; Tam CF; Lam KS
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):359-63. PubMed ID: 7750189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linear growth response to exogenous growth hormone in children with short stature.
    Schwartz ID; Hu CS; Shulman DI; Root AW; Bercu BB
    Am J Dis Child; 1990 Oct; 144(10):1092-7. PubMed ID: 2403090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.
    Maghnie M; Barreca A; Ventura M; Tinelli C; Ponzani P; De Giacomo C; Maggiore G; Severi F
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):747-55. PubMed ID: 9713564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth and pubertal development in transfusion-dependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study.
    Soliman AT; elZalabany M; Amer M; Ansari BM
    J Trop Pediatr; 1999 Feb; 45(1):23-30. PubMed ID: 10191589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Wit JM; Wolff ED; de Jong MC; Donckerwolcke RA; Abbad NC; Bot A; Blum WF
    Lancet; 1991 Sep; 338(8767):585-90. PubMed ID: 1715501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.
    Azcona C; Preece MA; Rose SJ; Fraser N; Rappaport R; Ranke MB; Savage MO
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):787-92. PubMed ID: 10619985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone treatment in short children with beta-thalassemia major.
    Katzos G; Papakostantinou-Athanasiadou E; Athanasiou-Metaxa M; Harsoulis F
    J Pediatr Endocrinol Metab; 2000 Feb; 13(2):163-70. PubMed ID: 10711661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome).
    Cotterill AM; Camacho-Hübner C; Holly JM; Savage MO
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):119-22. PubMed ID: 7688671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone secretion in adult patients with thalassaemia.
    La Rosa C; De Sanctis V; Mangiagli A; Mancuso M; Guardabasso V; Galati MC; Caruso-Nicoletti M
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):667-71. PubMed ID: 15943827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major.
    Sartorio A; Conte G; Conti A; Masala A; Alagna S; Rovasio P; Faglia G
    J Endocrinol Invest; 2000 Jun; 23(6):356-61. PubMed ID: 10908162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous and provoked growth hormone (GH) secretion and insulin-like growth factor I (IGF-I) concentration in patients with beta thalassaemia and delayed growth.
    Soliman AT; elZalabany MM; Mazloum Y; Bedair SM; Ragab MS; Rogol AD; Ansari BM
    J Trop Pediatr; 1999 Dec; 45(6):327-37. PubMed ID: 10667001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
    Cavallo L; Gurrado R; Zecchino C; Manolo F; De Sanctis V; Cisternino M; Caruso-Nicoletti M; Galati M
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():845-9. PubMed ID: 10091155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro response of erythroid progenitors from children with thalassaemia major to human growth hormone and insulin-like growth factor I.
    Merchav S; Graif Z; Skottner A
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):207-11. PubMed ID: 8370134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel application of IGF-I and IGFBP-3 generation tests in the diagnosis of growth hormone axis disturbances in children with beta-thalassaemia.
    Chrysis DC; Alexandrides TK; Koromantzou E; Georgopoulos N; Vassilakos P; Kiess W; Kratsch J; Beratis NG; Spiliotis BE
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):253-9. PubMed ID: 11207641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment.
    Wu KH; Tsai FJ; Peng CT
    Ann Hematol; 2003 Oct; 82(10):637-40. PubMed ID: 12898188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of human chorionic gonadotropin on growth velocity and biological growth parameters in adolescents with thalassaemia major.
    Bozzola M; Argente J; Cisternino M; Moretta A; Valtorta A; Biscaldi I; Donnadieu M; Evain-Brion D; Severi F
    Eur J Pediatr; 1989 Jan; 148(4):300-3. PubMed ID: 2495961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurosecretory dysfunction of growth hormone secretion in thalassemia major.
    Shehadeh N; Hazani A; Rudolf MC; Peleg I; Benderly A; Hochberg Z
    Acta Paediatr Scand; 1990; 79(8-9):790-5. PubMed ID: 2239274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.